| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 15 Jul 2026 | 9 Jul 2026 |
| Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/07/2026 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30 2026. AS ATTACHED (As Per BSE Announcement Dated on 15.07.2026) | ||
| Board Meeting | 4 Jul 2026 | 1 Jul 2026 |
| Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/07/2026 inter alia to consider and approve 1.Increase In Authorised Equity Share Capital of company From ?130000000 (Rupees Thirteen Crore Only) To ? 1000000000 (Rupees One Hundred Crore Only). 2. Alteration In Object Clause of MOA 3. Approve draft EGM notice 4. Appointment of scrutinizer for EGM AS ATTACHED (As Per BSE Announcement Dated on:04.07.2026) Revised Outcome of Board Meeting held on Saturday, July 4, 2026 (As per BSE Announcement dated on: 22.07.2026) | ||
| Board Meeting | 30 Apr 2026 | 28 Apr 2026 |
| Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 ,inter alia, to consider and approve standalone Audited financial results for the quarter and year ended 31st march 2026. Results - Standalone Audited Financial results for the quater and financial year ended on 31st March 2026. (As per BSE Announcement dated on: 30.04.2026) | ||
| Board Meeting | 18 Mar 2026 | 18 Mar 2026 |
| Outcome for Board Meeting Held on Today I.E., March 18, 2026 | ||
| Board Meeting | 14 Feb 2026 | 10 Feb 2026 |
| Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve the unaudited financial results for the quarter and nine months ended on 31st December 2025 Results for the quarter and nine months ended on 31st Dec 2025 (As per BSE Announcement dated on: 14.02.2026) | ||
| Board Meeting | 8 Dec 2025 | 8 Dec 2025 |
| Outcome of Board Meeting held on 08-12-2025 Intimation of appointment of additional directors of the Company | ||
| Board Meeting | 29 Nov 2025 | 21 Nov 2025 |
| Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/11/2025 inter alia to consider and approve unaudited financial results for the quarter and half year ended on 30th September 2025. Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/11/2025 ,inter alia, to consider and approve the unaudited financial results for the quarter and half year ended on 30th September 2025. (As per BSE Announcement dated on: 26.11.2025) Results - Financial Results 2025 (As per BSE Announcement dated on: 29.11.2025) | ||
| Board Meeting | 14 Nov 2025 | 5 Nov 2025 |
| Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Sarda Proteins Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve the standalone unaudited financial results of the Company for the quarter and half year ended September 30 2025 | ||
| Board Meeting | 8 Sep 2025 | 2 Sep 2025 |
| Inter alia to transact the following business: 1. To ascertain director, who shall be liable to retire by rotation; 2. To approve Boards Report along with all its Annexures including Management Discussion and Analysis Report, Secretarial Audit Report and Corporate Governance Report for the Financial Year 2024-25; 3. To fix day, date and time of 34th Annual General Meeting of the Company and to approve the Notice of Annual General Meeting; 4. To fix Book Closure period for 34th Annual General Meeting of the Company; 5. To appoint Scrutinizer to conduct remote Voting Process as well as Evoting at 34th Annual General Meeting of the Company; 6. To appoint Secretarial Auditor of the Company for the term of five years from F.Y. 2025-26 to F.Y. 2029-30; 7. To appoint Internal Auditor of the Company; 8. To appoint Statutory Auditor of the Company; 9. To appoint Cost Auditor of the Company; 10.Other ancillary and routine businesses. Outcome of Board Meeting held on 8th September, 2025 Corrigendum to Outcome of Board Meeting held on Monday, 08th September, 2025 Corrigendum to Outcome of Board Meeting - Intimation of Appointment of Internal Auditor for the Financial Year 2025-26 (As Per BSE Announcement Dated on 08.09.2025) | ||
| Board Meeting | 14 Aug 2025 | 12 Aug 2025 |
| Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve the Standalone Unaudited Financial Results for the Quarter ended 30th June 2025. We hereby submit outcome of Board Meeting held on August 14, 2025. (As Per BSE Announcement Dated on: 14.08.2025) | ||
| Board Meeting | 11 Aug 2025 | 6 Aug 2025 |
| Sarda Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2025 inter alia to consider and approve other businesses. Intimation of Board Meeting to be held on Monday (As Per BSE Announcement Dated on: 11.08.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
